-
My Account
In App
My Account
| Particulars | This Scheme | Category |
|---|---|---|
| No. of Stocks | 42 | 43.23 |
| Top 5 Stock Weight | 30.85% | 32.76% |
| Top 10 Stock Weight | 48.35% | 49.89% |
| Top 3 Sector Weight | 86.74% | 43.73% |
| Particulars | This Scheme | Category |
|---|---|---|
| Average mcap (Cr) | 26676.45 | 74170.21 |
| Holdings in large cap stocks | 29.74% | 37.75% |
| Holdings in mid cap stocks | 26.02% | 14.64% |
| Holdings in small cap stocks | 7.94% | 13.09% |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Pharmaceuticals | 250 | 7.75% | -0.11% | 9.27% (Apr 2025) | 0% (Oct 2024) | 43.94 k | 1.52 k |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 242.7 | 7.53% | 0.32% | 8.83% (Apr 2025) | 0% (Oct 2024) | 1.52 L | 2.60 k |
| - Apollo Hospitals Enterprises Ltd. | Hospital | 202.7 | 6.29% | 0.00% | 6.29% (Sep 2025) | 0% (Oct 2024) | 27.36 k | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 175.6 | 5.45% | -0.16% | 8.33% (Apr 2025) | 0% (Oct 2024) | 1.17 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 123.6 | 3.83% | 0.32% | 3.83% (Sep 2025) | 0% (Oct 2024) | 1.27 L | 0.00 |
| Neuland Laboratories Ltd. | Pharmaceuticals | 121.8 | 3.78% | 0.53% | 3.78% (Sep 2025) | 0% (Oct 2024) | 8.34 k | 350.00 |
| Biocon Ltd. | Pharmaceuticals | 115.8 | 3.59% | 0.14% | 4.24% (Jan 2025) | 0% (Oct 2024) | 3.40 L | 12.00 k |
| Aurobindo Pharma Ltd. : Futures Near | Pharmaceuticals | 110.8 | 3.44% | 0.00% | 3.44% (Sep 2025) | 0% (Oct 2024) | 1.02 L | 1.02 L |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 110.7 | 3.43% | -0.01% | 8.46% (Jan 2025) | 0% (Oct 2024) | 90.44 k | 0.00 |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals | 105 | 3.26% | -0.19% | 3.45% (Aug 2025) | 0% (Oct 2024) | 82.00 k | 0.00 |
| Stock Invested in |
Sector |
Sector Total |
Value(Mn) |
% of Total Holdings |
1M Change |
1Y Highest Holding |
1Y Lowest Holding |
Quantity |
1M Change in Qty |
M-Cap |
GroupName |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Pharmaceuticals | 67.39 | 250 | 7.75% | -0.11% | 9.27% (Apr 2025) | 0% (Oct 2024) | 43.94 k | 1.52 k | Large Cap | 29.74 |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 67.39 | 242.7 | 7.53% | 0.32% | 8.83% (Apr 2025) | 0% (Oct 2024) | 1.52 L | 2.60 k | Large Cap | 29.74 |
| - Apollo Hospitals Enterprises Ltd. | Hospital | 12.57 | 202.7 | 6.29% | 0.00% | 6.29% (Sep 2025) | 0% (Oct 2024) | 27.36 k | 0.00 | Mid Cap | 26.02 |
| Cipla Ltd. | Pharmaceuticals | 67.39 | 175.6 | 5.45% | -0.16% | 8.33% (Apr 2025) | 0% (Oct 2024) | 1.17 L | 0.00 | Large Cap | 29.74 |
| Fortis Healthcare Ltd. | Hospital | 12.57 | 123.6 | 3.83% | 0.32% | 3.83% (Sep 2025) | 0% (Oct 2024) | 1.27 L | 0.00 | Other | 35.05 |
| Neuland Laboratories Ltd. | Pharmaceuticals | 67.39 | 121.8 | 3.78% | 0.53% | 3.78% (Sep 2025) | 0% (Oct 2024) | 8.34 k | 350.00 | Small Cap | 7.94 |
| Biocon Ltd. | Pharmaceuticals | 67.39 | 115.8 | 3.59% | 0.14% | 4.24% (Jan 2025) | 0% (Oct 2024) | 3.40 L | 12.00 k | Mid Cap | 26.02 |
| Aurobindo Pharma Ltd. : Futures Near | Pharmaceuticals | 67.39 | 110.8 | 3.44% | 0.00% | 3.44% (Sep 2025) | 0% (Oct 2024) | 1.02 L | 1.02 L | Other | 35.05 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 67.39 | 110.7 | 3.43% | -0.01% | 8.46% (Jan 2025) | 0% (Oct 2024) | 90.44 k | 0.00 | Other | 35.05 |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals | 67.39 | 105 | 3.26% | -0.19% | 3.45% (Aug 2025) | 0% (Oct 2024) | 82.00 k | 0.00 | Other | 35.05 |
| DR. LAL PATHLABS Ltd. | Healthcare service provider | 6.78 | 104.3 | 3.24% | -0.10% | 3.34% (Aug 2025) | 0% (Oct 2024) | 33.46 k | 0.00 | Small Cap | 7.94 |
| Piramal Pharma Ltd. | Pharmaceuticals | 67.39 | 104.2 | 3.23% | 0.21% | 3.98% (Jan 2025) | 0% (Oct 2024) | 5.45 L | 0.00 | Other | 35.05 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 67.39 | 101.6 | 3.15% | 0.46% | 3.15% (Sep 2025) | 0% (Oct 2024) | 93.70 k | 7.04 k | Large Cap | 29.74 |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 67.39 | 95.6 | 2.97% | 0.12% | 3.51% (Jun 2025) | 0% (Oct 2024) | 48.96 k | 0.00 | Mid Cap | 26.02 |
| Pfizer Ltd. | Pharmaceuticals | 67.39 | 82.2 | 2.55% | 0.01% | 2.79% (Jun 2025) | 0% (Oct 2024) | 16.32 k | 0.00 | Mid Cap | 26.02 |
| Lupin Ltd. | Pharmaceuticals | 67.39 | 69.3 | 2.15% | 0.07% | 2.15% (Sep 2025) | 0% (Oct 2024) | 36.28 k | 0.00 | Large Cap | 29.74 |
| Ipca Laboratories Ltd. | Pharmaceuticals | 67.39 | 67.6 | 2.10% | -0.01% | 2.47% (Mar 2025) | 0% (Oct 2024) | 50.48 k | 0.00 | Other | 35.05 |
| Sanofi Consumer Healthcare India Ltd. | Pharmaceuticals | 67.39 | 65.4 | 2.03% | 0.05% | 2.17% (Jun 2025) | 0% (Oct 2024) | 13.86 k | 1.20 k | Other | 35.05 |
| Zydus Wellness Ltd. | Packaged foods | 2.46 | 63.1 | 1.96% | 0.28% | 1.96% (Sep 2025) | 0% (Oct 2024) | 1.38 L | 1.38 L | Other | 35.05 |
| Vijaya Diagnostic Centre Ltd. | Healthcare service provider | 6.78 | 61.7 | 1.91% | 0.03% | 1.94% (Jul 2025) | 0% (Oct 2024) | 61.72 k | 0.00 | Other | 35.05 |
| Godrej Consumer Products Ltd | Personal care | 3.41 | 58.3 | 1.81% | -0.07% | 1.88% (Aug 2025) | 0% (Oct 2024) | 50.00 k | 0.00 | Large Cap | 29.74 |
| GlaxoSmithKline Pharmaceuticals Ltd. | Pharmaceuticals | 67.39 | 55.7 | 1.73% | 0.04% | 2.63% (May 2025) | 0% (Oct 2024) | 20.95 k | 899.00 | Mid Cap | 26.02 |
| Shaily Engineering Plastics Ltd. | Plastic products - industrial | 1.68 | 54 | 1.68% | 0.01% | 1.68% (Sep 2025) | 0% (Oct 2024) | 24.81 k | 0.00 | Other | 35.05 |
| Medi Assist Healthcare Services Ltd. | Healthcare service provider | 6.78 | 52.5 | 1.63% | 0.09% | 1.63% (Sep 2025) | 0% (Oct 2024) | 1.01 L | 0.00 | Other | 35.05 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 67.39 | 51.8 | 1.61% | 0.08% | 1.61% (Sep 2025) | 0% (Oct 2024) | 9.56 k | 0.00 | Mid Cap | 26.02 |
| Abbott India Ltd. | Pharmaceuticals | 67.39 | 50.9 | 1.58% | -0.07% | 3.19% (Jun 2025) | 0% (Oct 2024) | 1.74 k | 0.00 | Mid Cap | 26.02 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 67.39 | 45.7 | 1.42% | 0.06% | 2.62% (Apr 2025) | 0% (Oct 2024) | 12.69 k | 0.00 | Mid Cap | 26.02 |
| Rainbow Childrens Medicare Ltd. | Hospital | 12.57 | 40 | 1.24% | -0.10% | 2.16% (Jun 2025) | 0% (Oct 2024) | 29.50 k | 0.00 | Other | 35.05 |
| Hindustan Unilever Ltd. | Diversified fmcg | 1.22 | 39.2 | 1.22% | -0.52% | 2.33% (Jan 2025) | 0% (Oct 2024) | 15.58 k | -6.07 k | Large Cap | 29.74 |
| Medplus Health Services Ltd. | Pharmacy retail | 1.21 | 39.1 | 1.21% | -0.10% | 1.41% (Jun 2025) | 0% (Oct 2024) | 51.65 k | 0.00 | Other | 35.05 |
| Max Healthcare Institute Ltd. | Hospital | 12.57 | 39 | 1.21% | -0.01% | 1.34% (Jun 2025) | 0% (Oct 2024) | 35.00 k | 0.00 | Other | 35.05 |
| Jubilant Life Sciences Ltd. | Pharmaceuticals | 67.39 | 37.8 | 1.17% | 0.09% | 1.28% (May 2025) | 0% (Oct 2024) | 34.99 k | 0.00 | Mid Cap | 26.02 |
| Alembic Pharmaceuticals Ltd. | Pharmaceuticals | 67.39 | 36 | 1.12% | -0.01% | 1.27% (May 2025) | 0% (Oct 2024) | 39.95 k | 0.00 | Mid Cap | 26.02 |
| Mankind Pharma Ltd. | Pharmaceuticals | 67.39 | 35.4 | 1.10% | 0.02% | 1.15% (Mar 2025) | 0% (Oct 2024) | 14.53 k | 0.00 | Other | 35.05 |
| Syngene International Ltd. | Healthcare research, analytics & technology | 1.07 | 34.3 | 1.07% | -1.86% | 3.25% (Jan 2025) | 0% (Oct 2024) | 55.14 k | -1.00 L | Mid Cap | 26.02 |
| AstraZeneca Pharma India Ltd. | Pharmaceuticals | 67.39 | 29.8 | 0.92% | 0.09% | 1.32% (Jun 2025) | 0% (Oct 2024) | 3.27 k | 0.00 | Small Cap | 7.94 |
| Emami Ltd. | Personal care | 3.41 | 29.6 | 0.92% | -0.39% | 1.52% (Apr 2025) | 0% (Oct 2024) | 55.00 k | -0.20 L | Mid Cap | 26.02 |
| Marico Ltd. | Personal care | 3.41 | 22 | 0.68% | -0.01% | 1.21% (Apr 2025) | 0% (Oct 2024) | 31.59 k | 0.00 | Large Cap | 29.74 |
| PB Fintech Ltd. | Financial technology (fintech) | 0.52 | 16.7 | 0.52% | -0.01% | 0.54% (Jun 2025) | 0% (Oct 2024) | 9.84 k | 0.00 | Other | 35.05 |
| Nestle India Ltd. | Packaged foods | 2.46 | 16 | 0.50% | 0.01% | 0.77% (Apr 2025) | 0% (Oct 2024) | 13.89 k | 0.00 | Other | 35.05 |
| Neogen Chemicals Ltd. | Specialty chemicals | 0.44 | 14.2 | 0.44% | 0.04% | 0.49% (May 2025) | 0% (Oct 2024) | 9.43 k | 0.00 | Other | 35.05 |
| # Suven Pharmaceuticals Ltd. | Pharmaceuticals | 67.39 | 10.5 | 0.33% | 0.33% | 0.33% (Sep 2025) | 0% (Oct 2024) | 11.99 k | 11.99 k | Other | 35.05 |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Suven Pharmaceuticals Ltd. | Pharmaceuticals | 10.5 | 0.33% | 0.33% | 0.33% (Sep 2025) | 0% (Oct 2024) | 11.99 k | 11985 |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| No complete exits in the portfolio in the last month. | ||||||||
| Stock | Sep 2025 | Aug 2025 | Jul 2025 | Jun 2025 | May 2025 | Apr 2025 | Mar 2025 | Feb 2025 | Jan 2025 | Dec 2024 | Nov 2024 | Oct 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | 7.75% | 7.86% | 7.94% | 8.67% | 8.71% | 9.27% | 8.88% | 9.15% | 8.74% | 5.99% | - | - | - |
| Sun Pharmaceutical Industries Ltd. | 7.53% | 7.21% | 7.48% | 7.55% | 7.82% | 8.83% | 8.44% | 8.42% | 8.65% | 7.98% | - | - | - |
| Cipla Ltd. | 5.45% | 5.61% | 5.32% | 6.08% | 6.61% | 8.33% | 7.82% | 8.29% | 7.17% | 6.12% | - | - | - |
| Apollo Hospitals Enterprises Ltd. | 6.29% | 6.29% | 6.01% | 5.96% | 5.86% | 5.76% | 5.51% | 5.00% | 5.28% | 1.87% | - | - | - |
| Dr. Reddys Laboratories Ltd. | 3.43% | 3.44% | 3.37% | 3.49% | 3.52% | 3.45% | 7.90% | 8.27% | 8.46% | 7.98% | - | - | - |
| Biocon Ltd. | 3.59% | 3.45% | 3.76% | 3.51% | 3.43% | 3.66% | 3.92% | 3.77% | 4.24% | 1.98% | - | - | - |
| Piramal Pharma Ltd. | 3.23% | 3.02% | 3.15% | 3.34% | 3.50% | 3.71% | 3.77% | 3.46% | 3.98% | 2.64% | - | - | - |
| Fortis Healthcare Ltd. | 3.83% | 3.51% | 3.20% | 2.44% | 1.72% | - | - | - | - | - | - | - | - |
| Neuland Laboratories Ltd. | 3.78% | 3.25% | 3.00% | 2.78% | 2.76% | 2.98% | 2.76% | 2.63% | 3.29% | 1.91% | - | - | - |
| Emcure Pharmaceuticals Ltd. | 3.26% | 3.45% | 3.39% | 3.19% | 3.40% | 2.70% | 2.48% | 2.43% | 2.85% | 1.25% | - | - | - |
| Syngene International Ltd. | 1.07% | 2.93% | 3.25% | 2.53% | 2.65% | 2.69% | 3.11% | 3.03% | 3.25% | 2.01% | - | - | - |
| Glenmark Pharmaceuticals Ltd. | 2.97% | 2.85% | 3.45% | 3.51% | 2.81% | 1.80% | 2.02% | 1.82% | 1.94% | 2.01% | - | - | - |
| Torrent Pharmaceuticals Ltd. | 1.42% | 1.36% | 2.42% | 2.51% | 2.42% | 2.62% | 2.57% | 2.46% | 2.56% | - | - | - | - |
| Ipca Laboratories Ltd. | 2.10% | 2.11% | 2.18% | 2.11% | 2.24% | 2.28% | 2.47% | 2.42% | 2.13% | 1.52% | - | - | - |
| DR. LAL PATHLABS Ltd. | 3.24% | 3.34% | 3.09% | 2.82% | 1.90% | 1.29% | 1.17% | 1.18% | 1.29% | - | - | - | - |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 2.97% |
| Net Receivables | Net Receivables | -1.72% |
Secure 9.70% returns with the PSU Bond that Brings Long-term Stability U.P. POWER CORPORATION LIMITED 2032 ✔️ Coupon: 9.70% ✔️ Rating: CRISIL A+(CE) Stable, INDIA RATING A+(CE) Stable ✔️ Tenor: 6y 4m (Maturity: 22/Mar/2032) Secure your investments with a PSU bond delivering consistent returns and state-backed stability. Senior Secured Bond | PSU Bond | High Return Bond | Listed ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dXhLc1lBPT0=/970-up-power-corporation-limited-2032?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more
Posted by : The Fixed Income
Repost this message
Secure 9.70% returns with the PSU Bond that Brings Long-term Stability U.P. POWER CORPORATION LIMITED 2032 ✔️ Coupon: 9.70% ✔️ Rating: CRISIL A+(CE) Stable, INDIA RATING A+(CE) Stable ✔️ Tenor: 6y 4m (Maturity: 22/Mar/2032) Secure your investments with a PSU bond delivering consistent returns and state-backed stability. Senior Secured Bond | PSU Bond | High Return Bond | Listed ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dXhLc1lBPT0=/970-up-power-corporation-limited-2032?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
need your suggestion for sbi psu fund direct growth stay or switch View more
Posted by : shravanashok
Dividend last declared by SBI Long Term Equity Fund - regular Plan -IDCW was in the year 2022. Is there any specific reason given by fund managers for non declaration of dividend. Please let me know. View more
Posted by : ravisistla
Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV. View more
Posted by : sunny85deol
